Archives

by in
Entry Author Date Location
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More 10/30/14 Seattle
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
Bristol-Myers Kicks Arthritis Drug Back to Alder, Shares Tumble 09/02/14 Seattle
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Biotech IPO Slump Deepens as Alder Prices Below Range 05/08/14 Seattle
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
Alder BioPharmaceuticals Hits IPO Trail Looking for $115M 03/19/14 Seattle
Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal 03/17/14 San Francisco
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
Molecular Diagnostics Are in a Rut. The Industry Needs the FDA 02/17/14 National
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Myriad Genetics Acquires Crescendo Bioscience for $270M 02/04/14 San Francisco
Fresh from IPO, Five Prime Advances Arthritis and Cancer Drugs 12/19/13 San Francisco
Bristol-Myers, Alder Drug for Rheumatoid Arthritis Passes Key Test 10/28/13 Seattle
Isis Ends Program, Still Has Options For Rheumatoid Arthritis Drug 08/05/13 San Diego
Using Frugal Business Model, Orphagen Targets Orphan Receptors 06/13/13 San Diego
San Diego Life Sciences Roundup: Effector, Ignyta, and More 05/23/13 San Diego
Big Data Is BS in Healthcare. When Will It Become Real? 04/15/13 National
Crescendo Bioscience Snags $28M For Arthritis Test 01/03/13 San Francisco
Innovimmune Pursues Pharma Partners, Shuns VCs 08/07/12 New York
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Crescendo Bioscience Takes Arthritis Into the World of Hard Data 02/24/12 San Francisco
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Sanofi Collaboration Drives Regeneron’s Transformation From R&D House to Commercial Player 07/13/11 New York
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News 06/23/11 Seattle
Pfizer Adds to Data on Novel RA Drug 04/28/11 New York
BG Medicine Chief Speaks on Rough IPO Climate, (Finally) Going Public 04/21/11 Boston
Pfizer Releases Top Line Data on Novel RA Drug 04/15/11 New York
Page 1 of 4 next page »